Announce Date | 05/01/2025 |
EPS Normalized Actual | $0.1301 (Miss by $-0.1799) |
EPS GAAP Actual | $0.1301 (Miss by $-0.1799) |
Revenue Actual | $0.327702B |
Revenue Surprise | Beat by $327.702M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.32 |
EPS GAAP Estimate | $0.32 |
Revenue Estimate | $0.387625B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 0 | INF | 0 | 0 | 0 |
Dec 2026 | 0.94 | 13.01 | 0.92021 | 0.95205 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.13 | -0.06 | 0.327702B | -0.55% | -12.88M |
FQ4 2024 (Dec 2024) | 0.12 | -0.1525 | 0.333036B | 6.18% | -51.51M |
FQ3 2024 (Sep 2024) | 0.23 | -0.0725 | 0.378843B | 5.43% | -6.07M |
FQ2 2024 (Jun 2024) | 0.31 | -1.03259 | 0.390077B | 7.29% | -236.88M |
FQ1 2024 (Mar 2024) | 0.22 | 0.22 | 0.329512B | 5.48% | 329.51M |
FQ4 2023 (Dec 2023) | 0.0903 | 0.0903 | 0.312456B | 4.27% | 312.46M |
FQ3 2023 (Sep 2023) | 0.26 | 0.26 | 0.35826B | 4.78% | 358.26M |
FQ1 2008 (Mar 2008) | -1985.2 | -1985.2 | 0B | NAN% | 0M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
0.32
Consensus Revenue Estimates
0.387625B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 0.14 | -- | 0.13862 | 0.14189 | 0 |
FQ3 2026 (Sep 2026) | 0.3 | -- | 0.29705 | 0.30404 | 0 |
FQ2 2026 (Jun 2026) | 0.33 | -- | 0.32676 | 0.33445 | 0 |
FQ1 2026 (Mar 2026) | 0.17 | 23.53 | 0.16833 | 0.17229 | 0 |
FQ4 2025 (Oct 2025) | 0.275 | 56.36 | 0.27159 | 0.27933 | 1 |
FQ3 2025 (Jul 2025) | 0.3 | 23.33 | 0.29628 | 0.30472 | 1 |
FQ2 2025 (Jun 2025) | 0.32 | 3.13 | 0.31045 | 0.3263 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 0.35B | -- | 0.35B | 0.35B | 4 |
FQ3 2026 (Sep 2026) | 0.4B | -- | 0.4B | 0.41B | 4 |
FQ2 2026 (Jun 2026) | 0.41B | -- | 0.41B | 0.42B | 4 |
FQ1 2026 (Mar 2026) | 0.35B | 5.42 | 0.34B | 0.35B | 4 |
FQ4 2025 (Oct 2025) | 0.4B | 16 | 0.39B | 0.4B | 1 |
FQ3 2025 (Jul 2025) | 0.4B | 4.12 | 0.39B | 0.4B | 1 |
FQ2 2025 (Jun 2025) | 0.39B | -0.63 | 0.38B | 0.39B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
5
EPS # of in-lines
0
Revenue # of Beats
3
Revenue # of Misses
4
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.19 | 0.13 | -0.06 | -46.15% |
FQ4 2024 (Dec 2024) | 0.2725 | 0.12 | -0.1525 | -127.08% |
FQ3 2024 (Sep 2024) | 0.3025 | 0.23 | -0.0725 | -31.52% |
FQ2 2024 (Jun 2024) | 1.34259 | 0.31 | -1.03259 | -333.09% |
FQ1 2024 (Mar 2024) | 0.22 | 0.22 | 100% | |
FQ4 2023 (Dec 2023) | 0.0903 | 0.0903 | 100% | |
FQ3 2023 (Sep 2023) | 0.26 | 0.26 | 100% | |
FQ1 2008 (Mar 2008) | -1985.2 | -1985.2 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0.34B | $0.33B | $-12.88M | -3.93% |
FQ4 2024 (Dec 2024) | $0.38B | $0.33B | $-51.51M | -15.47% |
FQ3 2024 (Sep 2024) | $0.38B | $0.38B | $-6.07M | -1.6% |
FQ2 2024 (Jun 2024) | $0.63B | $0.39B | $-236.88M | -60.73% |
FQ1 2024 (Mar 2024) | $0B | $0.33B | $329.51M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.31B | $312.46M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.36B | $358.26M | 100% |
FQ1 2008 (Mar 2008) | $0B | $0B | $0M | NAN% |